X T L Biopharmaceuticals Ltd
F:H2K2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X T L Biopharmaceuticals Ltd
F:H2K2
|
IL |
|
Arena.pl SA
F:8G6
|
PL |
|
W
|
Wowio Inc
OTC:WWIO
|
US |
|
Talon Capital Corp
NASDAQ:TLNC
|
US |
|
B
|
Bena Steel Industries Company SCJSC
SAU:9563
|
SA |
|
U
|
Union Korea Pharm Co Ltd
KOSDAQ:080720
|
KR |
|
Orpea SA
PAR:ORP
|
FR |
|
G
|
Grid Metals Corp
OTC:MSMGF
|
CA |
|
N
|
NORDWEST Handel AG
XMUN:NWX
|
DE |
|
G
|
Greek Organisation of Football Prognostics SA
OTC:GOFPY
|
GR |
|
Z
|
Zhongde Waste Technology AG
XHAM:ZEF
|
DE |
|
Access Co Ltd
TSE:4813
|
JP |
|
Emperor Energy Ltd
ASX:EMP
|
AU |
|
C
|
ClearVue Technologies Ltd
OTC:CVUEF
|
AU |
|
Hamilton Thorne Ltd
F:0ZM
|
US |
|
E
|
Eastern Resources Ltd
XBER:4LO
|
AU |
|
Audalia Resources Ltd
ASX:ACP
|
AU |
|
Clabo SpA
F:7UP
|
IT |
Bankruptcy Probability
X T L Biopharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
X T L Biopharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
X
|
X T L Biopharmaceuticals Ltd
TASE:XTLB
|
18.9m ILS |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
442.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
76.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
X T L Biopharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, X T L Biopharmaceuticals Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
